glatiramer (Copaxone, Glatopa) (cont.)

Pharmacy Author:
Medical and Pharmacy Editor:


  • The recommended dose for treating relapsing forms of MS is 20 mg injected under the skin daily or 40 mg injected under the skin 3 times a week (at least 48 hours apart).


  • Glatiramer's mechanism of action is not completely understood. Available data suggests that it may work by modifying immune processes by suppressing T-cells (white blood cells of the immune system) that cause inflammation and destruction of nerves in patients with MS . Glatiramer does not cure MS. It decreases the number of MS flares and lesions in the brain.
  • The FDA approved glatiramer in December, 1996.

REFERENCE: FDA Prescribing Information

Medically Reviewed by a Doctor on 6/10/2016

Report Problems to the Food and Drug Administration

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

Pill Finder Tool

Need help identifying pills and medications?
Use the pill identifier tool on RxList.

Back to Medications Index

Health Solutions From Our Sponsors